Glucotrack and Apimeds Pharmaceuticals US
Glucotrack, Inc. completed reverse merger with Apimeds Pharmaceuticals US, Inc. on July 9, 2026.
Company-confirmed: reported in the company's own SEC filing
Latest update Aug 28, 2026, 4:28 PM ET
- ✓Announced
- ✓Pending
- ✓Completed
Acquirer
Apimeds Pharmaceuticals USAPUSTarget
GlucotrackGCTK- Deal value
- Not disclosed
- the filing states none
- Offer
- Not disclosed
- Premium
- N/A
- Shown only for a signed all-cash price per share
- Expected close
- Not disclosed
- merger
Share prices around the disclosure
Daily closes, each set to 100 on the first day shown. The dashed lines mark the session that first reflects each public event.
